Can a noninvasive cardiac electrophysiology model personalized with body surface potential mapping accurately predict activation onset location and response to pacing?
Noninvasive personalization of cardiac electrophysiology models using body surface potential mapping can accurately predict activation onset and response to pacing, offering a potential tool for CRT patient selection.
GOAL: We use noninvasive data (body surface potential mapping, BSPM) to personalize the main parameters of a cardiac electrophysiological (EP) model for predicting the response to different pacing conditions. METHODS: First, an efficient forward model is proposed, coupling the Mitchell-Schaeffer transmembrane potential model with a current dipole formulation. Then, we estimate the main parameters of the cardiac model: activation onset location and tissue conductivity. A large patient-specific database of simulated BSPM is generated, from which specific features are extracted to train a machine learning algorithm. The activation onset location is computed from a Kernel Ridge Regression and a second regression calibrates the global ventricular conductivity. RESULTS: The evaluation of the results is done both on a benchmark dataset of a patient with premature ventricular contraction (PVC) and on five nonischaemic implanted cardiac resynchonization therapy (CRT) patients with a total of 21 different pacing conditions. Good personalization results were found in terms of the activation onset location for the PVC (mean distance error, MDE = 20.3 mm), for the pacing sites (MDE = 21.7 mm) and for the CRT patients (MDE = 24.6 mm). We tested the predictive power of the personalized model for biventricular pacing and showed that we could predict the new electrical activity patterns with a good accuracy in terms of BSPM signals. CONCLUSION: We have personalized the cardiac EP model and predicted new patient-specific pacing conditions. SIGNIFICANCE: This is an encouraging first step towards a noninvasive preoperative prediction of the response to different pacing conditions to assist clinicians for CRT patient selection and therapy planning.
Giffard‐Roisin et al. (Wed,) studied this question.